SeraCare Life Sciences, Inc. (SRLS) Tops Q1 EPS by 3c, Sales Top Expectations

February 10, 2012 7:04 AM EST
SeraCare Life Sciences, Inc. (NASDAQ: SRLS) reported Q1 EPS of $0.07, $0.03 better than the analyst estimate of $0.04. Revenue for the quarter came in at $11.4 million versus the consensus estimate of $11.05 million.

For earnings history and earnings-related data on SeraCare Life Sciences, Inc. (SRLS) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings